This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Yutaka Mikami: Innovator in Neuropsychiatric Treatments
Introduction
Yutaka Mikami is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of neuropsychiatric and digestive system treatments. His work focuses on developing innovative compounds that can aid in the treatment of various diseases.
Latest Patents
Mikami holds a patent for a compound known as 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine methanesulfonate. This compound acts as a Corticotropin Releasing Factor (CRF) antagonist, which is useful in treating neuropsychiatric and digestive system diseases. His patent demonstrates his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Yutaka Mikami is associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His work has garnered attention for its potential impact on treating complex health issues.
Collaborations
Mikami has collaborated with esteemed colleagues such as Toshiaki Matsui and Hiroshi Araki. These partnerships have contributed to the advancement of research and development in the pharmaceutical field.
Conclusion
Yutaka Mikami's contributions to the field of neuropsychiatric treatments through his innovative patent highlight his role as a significant inventor. His work continues to pave the way for new therapeutic options that can enhance the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile